3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
- Product Name
- 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
- CAS No.
- 2097982-05-1
- Chemical Name
- 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
- Synonyms
- 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
- CBNumber
- CB15909561
- Molecular Formula
- C13 H19 N5
- Formula Weight
- 245.32
- MOL File
- 2097982-05-1.mol
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Suppliers
- Tel
- 0755-4000505016 13380397412
- Fax
- 0755 28094224
- 3001272453@qq.com
- Country
- China
- ProdList
- 5047
- Advantage
- 50
- Tel
- 18576690171 17386083646
- 3001006472@qq.com
- Country
- China
- ProdList
- 11837
- Advantage
- 58
- Tel
- 13268215580
- scinova_sales@163.com
- Country
- China
- ProdList
- 7023
- Advantage
- 58
- Tel
- 13986652530
- 2851922763@qq.com
- Country
- China
- ProdList
- 7837
- Advantage
- 58
- Tel
- 18627753421 18627756402
- Fax
- QQ:3001051413
- 3001009495@qq.com
- Country
- China
- ProdList
- 19063
- Advantage
- 58
- Tel
- +8617320513646
- mike@molcoo.com
- Country
- China
- ProdList
- 9501
- Advantage
- 58
- Tel
- +8618627948422
- sale@hdimpurity.com
- Country
- China
- ProdList
- 3389
- Advantage
- 58
More
Less
View Lastest Price from 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- manufacturers
ShenZhen H&D Pharmaceutical Technology Co., LTD
- Product
- Tofacitinib Impurity J 2097982-05-1
- Price
- US $0.00-0.00/mg
- Min. Order
- 10mg
- Purity
- 0.98
- Supply Ability
- 10g
- Release date
- 2024-05-20
2097982-05-1, 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-Related Search:
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid
Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI)
(3S,4S)-Tofacitinib
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)-
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
(3R,4R)-3-[(6-amino-4-pyrimidinyl)methylamino]-4-methyl-β-oxo-1-Piperidinepropanenitrile
2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE
Tofacitinib Impurity 6